SCHEMBL22364164

SCHEMBL22364164

CCOC(=O)COc1cccc(-c2cncc(N)c2N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F9 P00740 1/20 0.48
▸ F10 P00742 1/20 0.48
▸ PPARA Q07869 2/20 0.46
▸ PPARG P37231 1/20 0.46
▸ PPID Q08752 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ GAA P10253 5/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.42
▸ CNR1 P21554 1/20 0.41
▸ SQOR Q9Y6N5 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ P2RY12 Q9H244 1/20 0.40
▸ GRM2 Q14416 1/20 0.40
▸ GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037741 0.76 HPGD (0.54) F9F10PPARAPPARGKDM4E
SCHEMBL9863137 0.75 PPARA (0.67) F9F10PPARAPPARGKDM4E
SCHEMBL29577774 0.75 TP53 (0.62) F9F10PPARAPPARGKDM4E
SCHEMBL655678 0.75 TP53 (0.62) F9F10PPARAPPARGKDM4E
SCHEMBL18439119 0.75 TDO2 (0.56) KDM4EHSD17B10MAPTHPGDALDH1A1
SCHEMBL7035256 0.74 PPARA (0.50) F9F10PPARAPPARGKDM4E
SCHEMBL11828515 0.73 PPARA (0.63) F9F10PPARAPPARGKDM4E
SCHEMBL16180353 0.72 F9 (0.54) F9F10PPARAPPARGKDM4E
SCHEMBL7028743 0.72 PPARA (0.60) F9F10PPARAPPARGKDM4E
SCHEMBL6494581 0.72 GAA (0.66) PPARAPPARGKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759799-B2 Indazole containing macrocycles and therapeutic uses thereof SAMUMED, LLC (US) 2020-09-01 — — US disclosed
US-10759799-B2 Indazole containing macrocycles and therapeutic uses thereof SAMUMED, LLC (US) 2020-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759799-B2 Indazole containing macrocycles and therapeutic uses thereof WNT1, WNT3, WNT3A F9 3910/4885F10 3722/4885PPARA 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback